Skip to content

About Us
Our Programs
News & Events
Investors
Contact Us

Search for:

Month: June 2022

Salarius Pharmaceuticals to Participate in BIO International Convention 2022

Back

Salarius Pharmaceuticals to Participate in BIO International Convention 2022

Read More

Search for:

Recent Posts

Salarius Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Salarius Provides Update on Strategic Review Process and Plans to Support Ongoing Seclidemstat Clinical Trials by Further Reducing Expenses
Salarius Pharmaceuticals Issued U.S. Patent for Next-Generation Targeted Protein Degraders
Investigator-initiated Phase 1/2 Clinical Trial Using Salarius Pharmaceuticals’ Seclidemstat in Combination with Azacitidine to Treat Hematologic Cancers Resumes Patient Enrollment
Salarius Completes FDA Type B Meeting for Seclidemstat Ewing Sarcoma Development Program

Recent Comments

Archives

Categories

Uncategorized

Meta

Log in
Entries feed
Comments feed
WordPress.org

About Us
Our Programs
News & Events
Investors
Contact Us

Like Us on Facebook
Follow Us on Twitter
Connect on LinkedIn

© 2024 Salarius Pharmaceuticals, Inc. All Rights Reserved. Privacy and Terms of Use